The FDA approved Aurobindo Pharma's sertraline hydrochloride oral concentrate for the treatment of anxiety and depression in adults. The Indian drugmaker's product is a generic formulation of Pfizer's Zoloft.
Published in Brief:
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan